Diabetic neuropathy will be the focus of August 6 Visiting Professor Lecture
Two eminent neurologists will visit Ann Arbor on August 6 to present their latest research findings at a Visiting Professor Lecture hosted by the A. Alfred Taubman Medical Research Institute at the University of Michigan.
Amanda Peltier, M.D., a clinician-scientists and assistant professor of neurology at Vanderbilt University in Nashville, is an authority in the field of diabetic neuropathy. Her research focuses on developing means to diagnose neuropathy at earlier stages where it may be treatable.
Dr. Peltier completed her residency in neurology in 2002, and her M.S. in clinical research design in 2005.She has been awarded the Samuel J. Roessler Memorial Medical Scholarship, and has been recognized by the Landacre Society, College of Medicine Research Honorary Society. She has also received the IFCN Young Investigator Fellowship Award.
Dr. Peltier has been awarded the Samuel J. Roessler Memorial Medical Scholarship, and has been recognized by the Landacre Society, College of Medicine Research Honorary Society. She has also received the IFCN Young Investigator Fellowship Award.
Troels Staehelin Jensen, M.D., DMSc, of the Aarhus University in Denmark, is a renowned expert in the neurophysiology of pain. As a clinician-scientist, he has extensively studied the neuropathology of pain and is the author of more than 300 scientific papers. He is chair of the Aarhus University Hospital Department of Neurology, a founder of the Danish Pain Research Center, has held numerous academic posts and is a past president of the International Association for the Study of Pain.
Dr. Peltier will speak about "Diabetic neuropathy: A tale of two diseases" at 9:30 a.m. on August 6. Dr. Jensen will present his lecture, "Mechanisms and evidence based treatment of neuropathic pain" at 10:30 a.m.
Both talks will take place in the Danto Auditorium of the U-M Cardiovascular Center. No registration is required; all are welcome to attend.
Click here for directions and parking information for the Danto Auditorium.
Stem cell symposium set for Sept. 19 in Ann Arbor
Dr. Eva Feldman will be among the speakers at the one-day event, which focuses on cutting-edge developments in stem-cell biology, epigenetics and regneratrive medicine.
Click here for details and registration.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
People who care
Institute welcomes new gift officer
Maria Muller has been appointed to work with connect donors with funding opportunities at the Taubman Institute.
Click here to read more.
news & events
Institute symposium set for Oct. 10
The A. Alfred Taubman Medical Research Institute will award the 2014 $100,000 Taubman Prize for Excellence in Translational Medical Science at its 7th annual symposium at 10 a.m. on Oct. 10.
Dr. Carl June, a physician-scientist who developed a personalized immunotherapy for leukemia using patients’ own T cells, will receive the honor and deliver the symposium's keynote address.
Click here for symposium details.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.